Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia in a Patient with Seronegative Arthritis: A Case Report

J Assoc Physicians India. 2023 Nov;71(11):100-102. doi: 10.59556/japi.71.0386.

Abstract

Acquired amegakaryocytic thrombocytopenia (AATP) is an uncommon cause of severe thrombocytopenia with preserved cells of other lineages, which can present with severe bleeding episodes. We report a case of a 45-year-old male with seronegative arthritis who was diagnosed with idiopathic thrombocytopenic purpura (ITP) and was being treated with steroids for ITP. Despite aggressive treatment, the patient had persistently low levels of platelets. In view of persistent thrombocytopenia, bone marrow biopsy was done and was diagnosed as Acquired Amegakaryocytic Thrombocytopenia (AATP). Patient was successfully treated with cyclosporine. Correct identification of AATP is essential because it can lead to life threatening bleeding manifestations and advance into Aplastic anemia or MDS. How to cite this article: N AM, Rajanna AH, Kamath N. Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia in a Patient with Seronegative Arthritis: A Case Report. J Assoc Physicians India 2023;71(11):100-102.

Publication types

  • Case Reports

MeSH terms

  • Arthritis* / diagnosis
  • Arthritis* / etiology
  • Bone Marrow Diseases
  • Cyclosporine / therapeutic use
  • Diagnostic Errors*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic* / complications
  • Purpura, Thrombocytopenic, Idiopathic* / diagnosis
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / etiology

Substances

  • Cyclosporine
  • Immunosuppressive Agents

Supplementary concepts

  • Acquired amegakaryocytic thrombocytopenia